Investigation Report on Trastuzumab in China, 2018-2022
SKU ID :CRI-11885670 | Published Date: 20-Jun-2018 | No. of pages: 30Description
TOC
Table of Contents
1 Trastuzumab-related Concepts
1.1 Indication
1.2 Development of Trastuzumab in China
2 Chinese Market Overview of Trastuzumab
2.1 Patents and Government Approval on Drugs
2.2 Major Manufacturers
2.3 Analysis of Potential Entrants
3 Sales of Trastuzumab in China, 2013-2017
3.1 Sales Value of Trastuzumab
3.1.1 Overall Sales Value
3.1.2 Sales Value in Different Regions
3.2 Sales Volume of Trastuzumab
3.2.1 Overall Sales Volume
3.2.2 Sales Volume in Trastuzumab Different Regions
3.3 Market Share of Trastuzumab in Different Dosage Forms
3.3.1 Market Share of Trastuzumab Dosage Forms by Sales Value
3.3.2 Market Share of Trastuzumab Dosage Forms by Sales Volume
4 Market Share of Trastuzumab Manufacturers in China, 2013-2017
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 Major Manufacturers and Reference Sales Price of Trastuzumab in Chinese Market, 2017-2018
5.1 GENENTECH
5.2 Shanghai Roche Pharmaceuticals Ltd.
6 Prospects of Chinese Trastuzumab Market, 2018-2022
6.1 Forecast on Market Size
6.2 Forecast on Market Trend
Part of Charts
Chart Sales Value of Trastuzumab in China, 2013-2017
Chart Sales Value of Trastuzumab in Different Regions, 2017
Chart Sales Volume of Trastuzumab in China, 2013-2017
Chart Sales Value and Market Share of Shanghai Roche's Trastuzumab in China, 2013-2017
Chart Sales Value and Market Share of GENENTECH's Trastuzumab in China, 2013-2017
Chart Sales Value and Market Share of Trastuzumab Injections in China, 2013-2017
Chart Sale Price of GENENTECH's Trastuzumab in Several Chinese Cities, 2017
Chart Forecast on Sales Value of Trastuzumab in China, 2018-2022
Tables & Figures
Companies
1 GENENTECH
2 Shanghai Roche Pharmaceuticals Ltd.
- PRICE
-
$2200$3300